Funder: Pfizer Inc.
Due Dates: April 15, 2026 (Full proposal submission deadline)
Funding Amounts: Up to C$100,000 per project; total program budget C$300,000; maximum project duration 24 months.
Summary: Supports Canadian organizations to advance innovative research and quality improvement projects optimizing biomarker testing for colorectal cancer patients, aiming for measurable and sustainable improvements in care.
Key Information: Only organizations (not individuals) are eligible; late applications will not be reviewed.